πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9878993

DNA-PK inhibitors for treatment of cancer

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9878996

2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric ox

Northwestern University Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9873718

Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeu

The Regents of the University of California Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9873685

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9873696

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868736

Deubiquitinase inhibitors and methods for use of the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9861621

LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Biomed Valley Discoveries, Inc. Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9862679

Potent and selective inhibitors of monoamine transporters; method of making; and use there

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856262

Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors

Medshine Discovery Inc. Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856264

Isoquinolinesulfonyl derivative as RHO kinase inhibitor

Medshine Discovery Inc. Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855305

Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and

Compass Therapeutics LLC Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855252

Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

PALVELLA THERAPEUTICS, INC. Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9849109

Autotaxin inhibitors and uses thereof

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9850207

Substituted piperidines as soluble epdxide hydrolase inhibitors

The Regents of the University of California Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9845332

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9839639

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840460

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840520

Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetyla

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833437

Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphyl

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9834568

Kinase inhibitors and their uses

Rigel Pharmaceuticals, Inc. Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833457

Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828352

Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enz

The Regents of the University of California Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828367

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828373

2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted